{"id":"NCT04010539","sponsor":"GlaxoSmithKline","briefTitle":"A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea","officialTitle":"A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-10-21","primaryCompletion":"2023-10-10","completion":"2023-10-10","firstPosted":"2019-07-08","resultsPosted":"2024-05-30","lastUpdate":"2024-05-30"},"enrollment":628,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Gonorrhea"],"interventions":[{"type":"DRUG","name":"Gepotidacin","otherNames":[]},{"type":"DRUG","name":"Ceftriaxone","otherNames":[]},{"type":"DRUG","name":"Azithromycin","otherNames":[]}],"arms":[{"label":"Participants receiving Gepotidacin","type":"EXPERIMENTAL"},{"label":"Participants receiving Ceftriaxone plus Azithromycin","type":"ACTIVE_COMPARATOR"}],"summary":"This is a phase III, randomized, multicenter, open-label study which will be performed to evaluate efficacy and safety of oral Gepotidacin compared to intramuscular (IM) ceftriaxone plus oral azithromycin for the treatment of uncomplicated urogenital infection caused by Neisseria gonorrhoeae (N. gonorrhoeae) in adolescent and adult participants. In this study, participants will be randomly assigned to receive either oral gepotidacin or IM ceftriaxone plus oral azithromycin.","primaryOutcome":{"measure":"Number of Participants With Culture-Confirmed Bacterial Eradication of Neisseria Gonorrhoeae (NG) From the Urogenital Site at the Test-Of-Cure (TOC) Visit (Day 4 to 8)","timeFrame":"Baseline (Day 1) and TOC visit (Day 4 to 8)","effectByArm":[{"arm":"Gepotidacin","deltaMin":187,"sd":null},{"arm":"Ceftriaxone Plus Azithromycin","deltaMin":186,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":"0.5072"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":29},"locations":{"siteCount":51,"countries":["United States","Australia","Germany","Mexico","Spain","United Kingdom"]},"refs":{"pmids":["40245902","37751016","36255258"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":309},"commonTop":["Diarrhoea","Nausea","Vomiting","Chlamydial infection","Flatulence"]}}